- After plunging to 16-yr low in H1, yields soar 31 bps post-Budget: Report
- Gold off seven-month low as dollar weakness outweighs firmer yields
- Here's what triggered Sensex's 1,145-point crash on Monday
- Regulatory authorities used intra-day trading curbs more often last year
- Jagran Prakashan surges 18% as firm plans to consider buyback on March 2
- Indian shares fall for fifth session as financials, Reliance weigh
- HUL, Colgate among Nomura's top picks in case of GST slab rejig
- Metal stocks shine in a weak mkt; Hindustan Copper, Hindalco jump up to 17%
- NTPC snaps 4-day winning streak, declines 3% on profit-taking
- Jubilant Foods hits 52-week high as analysts applaud Fides Food deal
Sensex skids 531 pts; RIL, IndusInd Bank dip 5%, pharma stocks outperform
India VIX ticked up 4 per cent
The benchmark S&P BSE Sensex settled the session at 48,347.6 levels, down 531 points or 1.09 per cent, dragged by Reliance Industries (down 5.6 per cent), IndusInd Bank (down 5.5 per cent), HCL Tech (down 3.86 per cent), and HDFC (down 1 per cent).
The Nifty50, meanwhile, gave up the 14,250-mark and closed at 14,239 levels, down 133 points or 0.93 per cent.
In the broader market, the S&P BSE MidCap index slipped 1.14 per cent to end at 18,547 levels, while the S&P BSE SmallCap index ended at 18,211 levels, down 1.15 per cent.
The volatility index, India VIX, ended nearly 4 per cent higher today at 23.25 levels.
Sectorally, pharma stocks outperformed the market with the Nifty Pharma index ending nearly 2 per cent higher. On the downside, the Nifty Realty and the Nifty IT index ended with a cut of 1 per cent.
Domestic markets will remain shut on Tuesday on account of Republic Day holiday.
Asian shares climbed to near all-time highs on Monday as concerns over rising Covid-19 cases and delays in vaccine supplies were eclipsed by optimism of a $1.9 trillion fiscal stimulus plan to help revive the US economy.
MSCI's broadest index of Asia-Pacific shares outside Japan rose to 726.46, while Japan's Nikkei rebounded from falls in early trading to be up 0.7 per cent. Australian shares added 0.4 per cent after the country's drug regulator approved the Pfizer/BioNTech COVID-19 vaccine with a phased rollout likely late next month. Chinese shares rose, with the blue-chip CSI300 index up 1.1 per cent. Hong Kong’s Hang Seng index leapt nearly 2 per cent led by technology stocks.
In Europe, stocks rose as gains in technology shares and upbeat earnings reports helped investors look past the possibility of extended lockdowns. The pan-European STOXX 600 index rose 0.4 per cent.
(With inputs from Reuters)